Physician profile
Boyd Jensen
NPI 1831506146
$3,655.15
in general payments reported to CMS, 2019-2025
22 companies · $371 in 2025
The $371 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $504 · 2021: $207 · 2022: $660 · 2023: $753 · 2024: $492 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,616.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,257.73 | 2019-2021 | |
| Depuy Synthes Sales INC. | $1,162.68 | 2022-2025 | Motoband, Fibergraft Aeridyan Matrix, Na |
| Nevro Corp. | $208.83 | 2022-2023 | Senza |
| Zimmer Biomet Holdings, INC. | $133.43 | 2021-2023 | Ceramentbone Void Filler |
| Medtronic, INC. | $125.57 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Kerecis Limited | $105.45 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Amgen INC. | $103.40 | 2024-2025 | Krystexxa |
| Smith+Nephew, INC. | $97.99 | 2023-2025 | Collagenase Santyl, Regranex, Renasys Go V2 Home |
| Bioventus LLC | $73.04 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Ani Pharmaceuticals, INC. | $62.18 | 2025 | Purified Cortrophin Gel |
| Paratek Pharmaceuticals, INC. | $54.27 | 2022-2023 | Nuzyra |
| Horizon Therapeutics Plc | $51.85 | 2023 | Krystexxa |
| Organogenesis INC. | $29.17 | 2023 | Puraply |
| Vertex Pharmaceuticals Incorporated | $28.12 | 2025 | |
| Convatec INC. | $27.43 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $25.38 | 2023 | Surgx, Xperience, Blastx |
| Kci USA, INC. | $23.26 | 2023 | Activ.A.C., V.A.C. Dermatac |
| Abbvie INC. | $22.60 | 2024 | |
| Lifenet Health | $18.58 | 2025 | Theragenesis Wound Matrix |
| Fidia Pharma USA INC. | $16.68 | 2022 | |
| Baxter Healthcare | $13.94 | 2023 | Artiss |
| Boston Scientific Corporation | $13.57 | 2024 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boyd Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.